Is Motiva Breast Augmentation the Right Selection for You? Clinical Insights from Apgujeong-dong Plastic Surgery
Why is selecting the appropriate implant technology critical for long-term breast surgery safety?
Patient safety and natural aesthetic results have become the primary benchmarks in modern aesthetic surgery. In Apgujeong-dong, breast enhancement patients increasingly prioritize long-term biocompatibility and natural physical behavior over simple volume increase. Traditional implants often presented challenges such as excessive capsular tension, synthetic rigidity, and higher rates of revision surgery. This article explores the science of modern cohesive gel implants and clinical protocols to help you make an informed decision.
Treatment timing: Surgical intervention is optimal when breast development is fully complete, typically after age 22, or when postpartum tissue atrophy has stabilized for at least six months.
Non-surgical care: Conservative management, such as autologous fat transfer or external structural support therapies, is reasonable for patients seeking mild volume adjustments without skin laxity, but cannot correct significant structural asymmetry.
Treatment selection: Final selection is guided by chest wall anatomy, tissue pinch-test thickness, pectoral muscle density, and individual recovery expectations.

What is the biological mechanism behind breast implants and how is capsular contracture prevented?
Capsular contracture is an immunological foreign body reaction characterized by the formation of an abnormally dense, constrictive collagen envelope around a synthetic breast implant, leading to breast firmness, distortion, and potential chronic pain. This progressive pathology starts when fibroblasts deposit collagen layers in response to the foreign biomaterial. According to multiple observational studies and meta-analyses published in the Aesthetic Surgery Journal (2021), surface micro-topography plays a major role in mitigating this process. Nano-surface shells allow closer integration with surrounding tissue, which reduces the persistent subclinical inflammation that drives capsule thickening.
Historically, highly textured surfaces were used to prevent implant migration; however, they have been largely discontinued globally due to rare chronic inflammatory risks such as Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Modern microtextured shells like Motiva provide enough mechanical friction to minimize displacement while preserving cellular-level safety. To ensure excellent outcomes, surgeons must meticulously plan the surgical pocket, taking into account the natural inframammary fold and chest wall symmetry.
| Implant Category | Surface Technology | Clinical Advantage | Clinical Limitation |
|---|---|---|---|
| Motiva Ergonomix | SmoothSilk Nano-surface | Highly biocompatible shell; reduces capsular contracture rates below 1%. | Requires precise surgical pocket dissection to prevent initial minor displacement. |
| Traditional Smooth | Polished smooth shell | Softest tactile feel and highly cost-effective option. | Higher risk of displacement and mild tissue friction over time. |
According to official guidelines from the International Society of Aesthetic Plastic Surgery (ISAPS, 2022), both quantitative soft tissue metrics and clinical judgment regarding chest wall geometry should be reviewed together prior to implant selection.

How can patients evaluate their readiness for surgical breast enhancement?
Before undergoing surgery in Apgujeong-dong, prospective patients must receive a comprehensive clinical diagnostic evaluation. Ultrasound screening is utilized to check parenchymal health and identify any pre-existing lesions. However, outcomes may differ in exceptional cases such as patients with severe chest wall deformities like pectus excavatum or those who have undergone previous chest wall radiation therapy. For the vast majority of healthy candidates, following a structured decision flow path ensures predictable and safe results.
Candidacy Checklist:
- No active localized or systemic breast infections.
- Adequate soft tissue thickness (minimum 2 cm pinch test at the upper pole) for reliable implant coverage.
- Realistic expectations regarding postoperative scar maturation and physical restrictions.
- Stable psychological health and commitment to the 6-month post-operative recovery protocol.
- Absence of uncontrolled autoimmune or connective tissue disorders.
If-Then Decision Flow:
- Step 1 (Tissue Evaluation): If the patient presents with a pinch test of less than 2 cm, then a submuscular or dual-plane pocket plane is indicated to prevent implant visibility.
- Step 2 (Viscoelastic Choice): If the patient seeks a highly natural profile during motion, then Motiva Ergonomix with dynamic cohesive gel is the optimal choice.
- Step 3 (Reconstruction vs. Augmentation): If severe asymmetry exists, then a combination of asymmetric implant profiles and unilateral tissue adjustments is required.
Frequently Asked Questions FAQ
QIs post-operative massage required after Motiva breast surgery?
Unlike old-generation textured or smooth implants, modern microtextured or nano-surface implants like Motiva do not require manual massage. In fact, aggressive massage can interfere with the biological integration of the implant and surrounding tissue during the early healing phase.
QHow long does the recovery take before returning to daily activities?
Most patients can return to sedentary office work within 3 to 5 days. However, strenuous physical exercise, heavy lifting, and upper body workouts should be avoided for at least 4 to 6 weeks to ensure proper implant stabilization and scar healing.
QCan Motiva implants rupture, and what is the safety protocol?
Motiva implants are designed with BluSeal technology, which provides a visual safety barrier to prevent gel diffusion, and high viscoelasticity to resist rupture. In the highly rare event of a rupture, the cohesive gel remains contained, and the device is covered by a manufacturer-backed warranty program.

This content is general medical information, and individual treatment decisions should be made through imaging tests and in-person medical evaluation.
Author: Medical content editor based on medical information research
Reviewed by: Specialist consultation from the relevant department
Last reviewed: 2026-06-17
Reference guideline: 2022 International Society of Aesthetic Plastic Surgery (ISAPS) Clinical Consensus Guidelines
Medical neutrality and closing note
The core of medical decision-making is not to follow a specific device or a trending procedure, but to choose an option that fits each patient’s individual anatomy, condition, risk level, and treatment goals. Every procedure has both advantages and limitations, so decisions should be made after sufficient discussion with an experienced specialist.
[Medical information and copyright notice]
This content is a professional medical column prepared based on medical consultation from 제이케이성형외과의원.
The infographics used in this article are created to support understanding and may differ from actual clinical results.
The information provided is a general medical guideline, and accurate diagnosis and treatment require an in-person evaluation by a qualified specialist.